Treating erectile dysfunction with sildenafil alone versus combined with vitamin D3 in patients with low serum 25-hydroxy vitamin D3: a prospective randomized controlled open trial
This study aimed to compare the efficacy and risk of adverse events of sildenafil plus vitamin D3 versus sildenafil alone in improving erectile dysfunction (ED) in ED patients with low serum 25-hydroxy vitamin D3 (25-(OH)D3). The clinical data of ED patients with low serum 25-(OH)D3 treated at o...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MRE Press
2023-05-01
|
| Series: | Journal of Men's Health |
| Subjects: | |
| Online Access: | https://oss.jomh.org/files/article/20230530-21/pdf/JOMH16051.pdf |
| _version_ | 1797327475204685824 |
|---|---|
| author | Kang Yang Hui Jiang Xiansheng Zhang |
| author_facet | Kang Yang Hui Jiang Xiansheng Zhang |
| author_sort | Kang Yang |
| collection | DOAJ |
| description | This study aimed to compare the efficacy and risk of adverse events of
sildenafil plus vitamin D3 versus sildenafil alone in improving erectile
dysfunction (ED) in ED patients with low serum 25-hydroxy vitamin D3
(25-(OH)D3). The clinical data of ED patients with low serum 25-(OH)D3
treated at our center from December 2015 to December 2020 were retrieved, and the
patients (n = 157) were randomly divided into an experimental group (n = 80) or a
control group (n = 77). The experimental group was treated with 1 capsule of
vitamin D3 (400u) daily for a month and advised to use 100 mg sildenafil
(po) within 1 hour before sexual intercourse, while the control group was only
given 100 mg sildenafil (po) 1 hour before sexual intercourse. The indexes of
international erectile function (IIEF-5), serum 25-(OH)D3 level,
testosterone (T) level and adverse events between the two groups were compared
before and after treatment. The results showed that the IIEF-5 values of the two
groups were significantly higher after treatment than before treatment (p
< 0.05). However, the serum levels of 25-(OH)D3 and T in the experimental
group were significantly higher than before treatment (p < 0.05),
while no significant differences were observed in the same markers in the control
group before and after treatment (p > 0.05). The overall effective
rate, serum 25-(OH)D3 level and T level in the experimental group were
significantly higher than the control group (p < 0.05). During the
treatment, no significant difference in adverse events was observed between the
two groups (p > 0.05), which mostly comprised mild and tolerable
headache, dyspepsia, back pain and muscle soreness, not requiring any medical
intervention. Although both methods could effectively treat ED patients
with low 25-(OH)D3, the efficacy of sildenafil plus vitamin D3 was
significantly superior to sildenafil alone, and the adverse reactions are mild
and tolerable, which is worthy of clinical application. |
| first_indexed | 2024-03-08T06:38:10Z |
| format | Article |
| id | doaj.art-4eb7b8c6ae8e4cf191b442d197c2d2fb |
| institution | Directory Open Access Journal |
| issn | 1875-6859 |
| language | English |
| last_indexed | 2024-03-08T06:38:10Z |
| publishDate | 2023-05-01 |
| publisher | MRE Press |
| record_format | Article |
| series | Journal of Men's Health |
| spelling | doaj.art-4eb7b8c6ae8e4cf191b442d197c2d2fb2024-02-03T09:31:05ZengMRE PressJournal of Men's Health1875-68592023-05-0119571310.22514/jomh.2023.036S1875-6867(23)00005-2Treating erectile dysfunction with sildenafil alone versus combined with vitamin D3 in patients with low serum 25-hydroxy vitamin D3: a prospective randomized controlled open trialKang Yang0Hui Jiang1Xiansheng Zhang2Department of Urology, The First Affiliated Hospital of Anhui Medical University, 230000 Hefei, Anhui, ChinaDepartment of Urology, Peking University First Hospital Institute of Urology, Peking University Andrology Center, Peking University First Hospital, 100034 Beijing, ChinaDepartment of Urology, The First Affiliated Hospital of Anhui Medical University, 230000 Hefei, Anhui, ChinaThis study aimed to compare the efficacy and risk of adverse events of sildenafil plus vitamin D3 versus sildenafil alone in improving erectile dysfunction (ED) in ED patients with low serum 25-hydroxy vitamin D3 (25-(OH)D3). The clinical data of ED patients with low serum 25-(OH)D3 treated at our center from December 2015 to December 2020 were retrieved, and the patients (n = 157) were randomly divided into an experimental group (n = 80) or a control group (n = 77). The experimental group was treated with 1 capsule of vitamin D3 (400u) daily for a month and advised to use 100 mg sildenafil (po) within 1 hour before sexual intercourse, while the control group was only given 100 mg sildenafil (po) 1 hour before sexual intercourse. The indexes of international erectile function (IIEF-5), serum 25-(OH)D3 level, testosterone (T) level and adverse events between the two groups were compared before and after treatment. The results showed that the IIEF-5 values of the two groups were significantly higher after treatment than before treatment (p < 0.05). However, the serum levels of 25-(OH)D3 and T in the experimental group were significantly higher than before treatment (p < 0.05), while no significant differences were observed in the same markers in the control group before and after treatment (p > 0.05). The overall effective rate, serum 25-(OH)D3 level and T level in the experimental group were significantly higher than the control group (p < 0.05). During the treatment, no significant difference in adverse events was observed between the two groups (p > 0.05), which mostly comprised mild and tolerable headache, dyspepsia, back pain and muscle soreness, not requiring any medical intervention. Although both methods could effectively treat ED patients with low 25-(OH)D3, the efficacy of sildenafil plus vitamin D3 was significantly superior to sildenafil alone, and the adverse reactions are mild and tolerable, which is worthy of clinical application.https://oss.jomh.org/files/article/20230530-21/pdf/JOMH16051.pdfsildenafilvitamin d3erectile dysfunction25-hydroxy vitamin d3 |
| spellingShingle | Kang Yang Hui Jiang Xiansheng Zhang Treating erectile dysfunction with sildenafil alone versus combined with vitamin D3 in patients with low serum 25-hydroxy vitamin D3: a prospective randomized controlled open trial Journal of Men's Health sildenafil vitamin d3 erectile dysfunction 25-hydroxy vitamin d3 |
| title | Treating erectile dysfunction with sildenafil alone versus combined with
vitamin D3 in patients with low serum 25-hydroxy vitamin D3: a
prospective randomized controlled open trial |
| title_full | Treating erectile dysfunction with sildenafil alone versus combined with
vitamin D3 in patients with low serum 25-hydroxy vitamin D3: a
prospective randomized controlled open trial |
| title_fullStr | Treating erectile dysfunction with sildenafil alone versus combined with
vitamin D3 in patients with low serum 25-hydroxy vitamin D3: a
prospective randomized controlled open trial |
| title_full_unstemmed | Treating erectile dysfunction with sildenafil alone versus combined with
vitamin D3 in patients with low serum 25-hydroxy vitamin D3: a
prospective randomized controlled open trial |
| title_short | Treating erectile dysfunction with sildenafil alone versus combined with
vitamin D3 in patients with low serum 25-hydroxy vitamin D3: a
prospective randomized controlled open trial |
| title_sort | treating erectile dysfunction with sildenafil alone versus combined with vitamin d3 in patients with low serum 25 hydroxy vitamin d3 a prospective randomized controlled open trial |
| topic | sildenafil vitamin d3 erectile dysfunction 25-hydroxy vitamin d3 |
| url | https://oss.jomh.org/files/article/20230530-21/pdf/JOMH16051.pdf |
| work_keys_str_mv | AT kangyang treatingerectiledysfunctionwithsildenafilaloneversuscombinedwithvitamind3inpatientswithlowserum25hydroxyvitamind3aprospectiverandomizedcontrolledopentrial AT huijiang treatingerectiledysfunctionwithsildenafilaloneversuscombinedwithvitamind3inpatientswithlowserum25hydroxyvitamind3aprospectiverandomizedcontrolledopentrial AT xianshengzhang treatingerectiledysfunctionwithsildenafilaloneversuscombinedwithvitamind3inpatientswithlowserum25hydroxyvitamind3aprospectiverandomizedcontrolledopentrial |